Jim Cramer's Mad Money In-Depth Stock Picks, Oct.6
-
Font Size:
Good Taste: Senomyx (SNMX), Coca-Cola (KO), Kraft Foods (KFT), Cadbury Schweppes (CSG) and Campbell Soup (CPB)
Although it has "massive losses and barely any revenues," Senomyx will be a buy in a week or two according to Cramer because it has a new drug in the pipeline which mimicks the flavor of sweet and salty foods and which uses its active ingredient in such small quantities that it can bypass the FDA. Cramer adds that SNMX is strictly a speculative play. SNMX has made deals with KO, KFT, CPB and Cadbury Schweppes. Although the company will receive only 4% royalties from its product, Cramer believes that this should increase and that it has a good balance sheet and abundant cash flow which should offset its prior losses.
Merck (MRK) and Genentech (DNA)
When he was working for Goldman Sachs (GS) in 1986, Cramer spoke to a doctor who was testing an anti-cholesterol statin drug which was being sponsored by Merck (MRK). When Cramer decided to buy up a large number of MRK shares, an analyst laughed at him and thought the statin drug was "hype" until Cramer laughed all the way to the bank, made a few of his clients a fortune and was able to start his hedge fund. Cramer mentions this story because he feels that Genentech's anti-cancer drug Avastin, which is unique because it actually starves tumors, could enjoy the same success. He suggests picking up half of a position this week and the other half next week after DNA reports.
Global Signal (GSL), Crown Castle (CCI), Dell (DELL), Infosys Technologies (INFY), Monsanto (MO), Costco (COST), Gannett (GCI), Cadbury Schweppes (CSG), Google (GOOG), and Alaska Communications Systems' (ALSK)
A year ago, Cramer suggested picking up GSL which is now being bough by CCI. These were good long-term stocks, but Cramer selected some short-term plays for the week starting October 8th while telling investors to avoid Dell (DELL), a company that "needs a makeover" and more call centers. He said that Infosys Technologies (INFY) should be purchased early in the week before it reports since it rises even with bad news and is a good way to play the secular growth trend toward Indian call centers. Cramer suggests picking up his favorite biotech Monsanto before its report on Wednesday. He also likes Costco and the newspaper stock Gannett which has "actual revenue growth" and a "great risk reward." Cramer recommends picking up Google if it buys YouTube which should cause it to rise to $500. Moving on to his "Mad Mail" segment, Cramer replied to a question about ALSK's negative P/E by saying that the company had been losing money but was picking up steam.
Related: Phil Davis is bullish on Gannett.
More: Cramer's latest stock picks, including: Mad Money Recap, Lightening Round, Stop Trading and his Radio Show.
Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.
Seeking Alpha is not affiliated with CNBC, Jim Cramer or TheStreet.com.
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
-
Editor's Picks
-
Most Popular
- Assurant Is A Compelling Short Sell
- Broadcom Enters FTTH Chipset Market
- Another Macroshares Oil Arbitrage Opportunity
- Freeport McMoran: With Copper Prices Rising, It's Still a Buy
- Oil and the Futures Market
- Three Ways to Cash In on Record Meat and Dairy Prices
- Full list of Editor's Picks »
- High Likelihood of a Market Crash »
- Time To Start Buying Some Dogs? »
- Sirius-XM Combination: A Future Microsoft Acquisition? »
- JP Morgan Offer for Wachovia Makes Sense »
- High-Yield Canadian Royalty Trusts: What's the Catch? »
- Adding to My GE Position »
- 7 Stocks for a High Yield Cash Flow Portfolio »
- Drybulk Shipping: Prepare for a New Record High »
- Nokia: Bargain of a Lifetime - Barron's »
- Top 10 Payout Yield Stocks »
- Wall Street Breakfast: Must-Know News »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Adding Wood to Your Portolio: A Worthwhile Investment
- Arkansas Steel: 10 Structural Changes That Should Trump the Business Cycle
- Gross Margin Drivers at Potash Corp. (Part II)
- A New Strategy for EXACT Sciences
- Cytori Therapeutics: The Stem Cell 'Celution' for Success
- LDK Solar: The Brightest Opportunity?
- Big Lots, Wal-Mart and Costco: 3 Musketeers of the Pooring of America
- What's Behind Hansen's Smackdown?
- The Long Case for China Medical Technologies
- ASA Limited: A Golden Opportunity
- Full list of Long Ideas »
- Crystal River’s Q2 Write-Downs Could Bankrupt the Company
- Assurant Is A Compelling Short Sell
- Fuel Systems Solutions: Time to Take Profits
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Pair Trade Visa and Capital One
- Amazon's Kindle Numbers: All Fluff, Zero Substance
- A. Schulman: Cashless Profits
- Titan Machinery: Doesn't Anybody Look at Valuation?
- Goodrich Petroleum: Gas in the Ground Doesn't Mean Cash in the Bank
- Outlook Remains Grim for MBIA, Ambac
- Full list of Short Ideas »
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Momentum Stocks Stalled - Cramer's Stop Trading! (7/3/08)
- Expecting a Lift for Pediatrix: Cramer's Mad Money (7/3/08)
- The Most Bullish Thing - Cramer's Stop Trading! (7/1/08)
- Exelon's Got Nukes - Cramer's Lightning Round (7/1/08)
- Prescription Prediction for Allscripts - Cramer's Mad Money (7/1/08)
- Rex Marks the Spot - Cramer's Lightning Round, (6/30/08)
- Medicare Bill Buys - Cramer's Mad Money (6/30/08)
- Cracker Bottom of the Barrel - Cramer's Lightning Round (6/27/08)
- Britannia Bulk Rules the Waves - Cramer's Mad Money (6/27/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email


